Literature DB >> 23732854

Mesolimbic dopamine and habenulo-interpeduncular pathways in nicotine withdrawal.

John A Dani1, Mariella De Biasi.   

Abstract

The majority of people who attempt to quit smoking without some assistance relapse within the first couple of weeks, indicating the increased vulnerability during the early withdrawal period. The habenula, which projects via the fasciculus retroflexus to the interpeduncular nucleus, plays an important role in the withdrawal syndrome. Particularly the α2, α5, and β4 subunits of the nicotinic acetylcholine receptor have critical roles in mediating the somatic manifestations of withdrawal. Furthermore, withdrawal from nicotine induces a hypodopaminergic state, but there is a relative increase in the sensitivity to phasic dopamine release that is caused by nicotine. Therefore, acute nicotine re-exposure causes a phasic DA response that more potently reinforces relapse to smoking during the withdrawal period.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23732854      PMCID: PMC3662347          DOI: 10.1101/cshperspect.a012138

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  131 in total

1.  Cholinergic drugs for Alzheimer's disease enhance in vitro dopamine release.

Authors:  Lifen Zhang; Fu-Ming Zhou; John A Dani
Journal:  Mol Pharmacol       Date:  2004-09       Impact factor: 4.436

Review 2.  Nicotine use in schizophrenia: the self medication hypotheses.

Authors:  Veena Kumari; Peggy Postma
Journal:  Neurosci Biobehav Rev       Date:  2005       Impact factor: 8.989

3.  Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors.

Authors:  U Maskos; B E Molles; S Pons; M Besson; B P Guiard; J-P Guilloux; A Evrard; P Cazala; A Cormier; M Mameli-Engvall; N Dufour; I Cloëz-Tayarani; A-P Bemelmans; J Mallet; A M Gardier; V David; P Faure; S Granon; J-P Changeux
Journal:  Nature       Date:  2005-07-07       Impact factor: 49.962

4.  DeltaFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment.

Authors:  Linda I Perrotti; Carlos A Bolaños; Kwang-Ho Choi; Scott J Russo; Scott Edwards; Paula G Ulery; Deanna L Wallace; David W Self; Eric J Nestler; Michel Barrot
Journal:  Eur J Neurosci       Date:  2005-05       Impact factor: 3.386

Review 5.  Nicotine addiction.

Authors:  Neal L Benowitz
Journal:  N Engl J Med       Date:  2010-06-17       Impact factor: 91.245

6.  Periaqueductal gray afferents synapse onto dopamine and GABA neurons in the rat ventral tegmental area.

Authors:  Natalia Omelchenko; Susan R Sesack
Journal:  J Neurosci Res       Date:  2010-04       Impact factor: 4.164

7.  Nicotine amplifies reward-related dopamine signals in striatum.

Authors:  Margaret E Rice; Stephanie J Cragg
Journal:  Nat Neurosci       Date:  2004-05-16       Impact factor: 24.884

8.  Frequency-dependent modulation of dopamine release by nicotine.

Authors:  Hui Zhang; David Sulzer
Journal:  Nat Neurosci       Date:  2004-05-16       Impact factor: 24.884

9.  Mortality in relation to smoking: 50 years' observations on male British doctors.

Authors:  Richard Doll; Richard Peto; Jillian Boreham; Isabelle Sutherland
Journal:  BMJ       Date:  2004-06-22

Review 10.  Dopamine signals for reward value and risk: basic and recent data.

Authors:  Wolfram Schultz
Journal:  Behav Brain Funct       Date:  2010-04-23       Impact factor: 3.759

View more
  13 in total

Review 1.  Nicotine withdrawal.

Authors:  Ian McLaughlin; John A Dani; Mariella De Biasi
Journal:  Curr Top Behav Neurosci       Date:  2015

Review 2.  Anxiety and Nicotine Dependence: Emerging Role of the Habenulo-Interpeduncular Axis.

Authors:  Susanna Molas; Steven R DeGroot; Rubing Zhao-Shea; Andrew R Tapper
Journal:  Trends Pharmacol Sci       Date:  2016-11-24       Impact factor: 14.819

3.  Therapeutic concentrations of varenicline in the presence of nicotine increase action potential firing in human adrenal chromaffin cells.

Authors:  Arik J Hone; J Michael McIntosh; Lola Rueda-Ruzafa; Juan Passas; Cristina de Castro-Guerín; Jesús Blázquez; Carmen González-Enguita; Almudena Albillos
Journal:  J Neurochem       Date:  2016-12-09       Impact factor: 5.372

Review 4.  The habenulo-interpeduncular pathway in nicotine aversion and withdrawal.

Authors:  Beatriz Antolin-Fontes; Jessica L Ables; Andreas Görlich; Inés Ibañez-Tallon
Journal:  Neuropharmacology       Date:  2014-12-02       Impact factor: 5.250

Review 5.  Glial cells as therapeutic targets for smoking cessation.

Authors:  Mohit Kumar; Adewale Adeluyi; Erin L Anderson; Jill R Turner
Journal:  Neuropharmacology       Date:  2020-05-24       Impact factor: 5.250

6.  Expression of mu opioid receptor in dorsal diencephalic conduction system: new insights for the medial habenula.

Authors:  O Gardon; L Faget; P Chu Sin Chung; A Matifas; D Massotte; B L Kieffer
Journal:  Neuroscience       Date:  2014-07-31       Impact factor: 3.590

7.  Female rats display greater nicotine withdrawal-induced cellular activation of a central portion of the interpeduncular nucleus versus males: A study of Fos immunoreactivity within provisionally assigned interpeduncular subnuclei.

Authors:  Felix Matos-Ocasio; Veronika E Espinoza; Paola Correa-Alfonzo; Arshad M Khan; Laura E O'Dell
Journal:  Drug Alcohol Depend       Date:  2021-02-16       Impact factor: 4.492

8.  Amino acid systems in the interpeduncular nucleus are altered in a sex-dependent manner during nicotine withdrawal.

Authors:  Luis M Carcoba; Kevin P Uribe; Sebastian Ortegon; Ian A Mendez; Mariella DeBiasi; Laura E O'Dell
Journal:  J Neurosci Res       Date:  2021-03-22       Impact factor: 4.433

Review 9.  Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?

Authors:  Kenneth Blum; Marcelo Febo; Panayotis K Thanos; David Baron; James Fratantonio; Mark Gold
Journal:  Mol Neurobiol       Date:  2015-03-10       Impact factor: 5.590

Review 10.  Dopaminergic and cholinergic learning mechanisms in nicotine addiction.

Authors:  Manivannan Subramaniyan; John A Dani
Journal:  Ann N Y Acad Sci       Date:  2015-08-24       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.